Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Current therapy 2001].

A J Scheen1

  • 1Service de Médecine interne générale, Service de Diabétologie, Nutrition et Maladies metaboliques, Département de Médecine, Université de Liège.

Revue Medicale De Liege
|November 13, 2001
PubMed
Summary
This summary is machine-generated.

This review covers key new drugs for internal medicine in Belgium, detailing their characteristics and appropriate clinical use for healthcare professionals.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Sitagliptine (Januvia): incretin enhancer potentiating insulin secretion for the treatment of type 2 diabetes].

Revue medicale de Liege·2008
Same author

[Medication of the month. Rimonabant (Acomplia): first CB1 receptor antagonist of the endocannabinoid system].

Revue medicale de Liege·2008
Same author

[Isolated tricuspid valve endocarditis as a cause of fever of unknown origin].

Revue medicale de Liege·2008
Same author

[A first drug combination for the treatment of arterial hypertension with a calcium channel antagonist (amlodipine besylate) and an angiotensin receptor blocker (valsartan): Exforge].

Revue medicale de Liege·2008
Same author

[Therapy of type 2 diabetes: between insulin sensitizers and insulin secreting agents].

Revue medicale de Liege·2008
Same author

[Aspirin resistance in diabetic patients: laboratory entity or clinical reality?].

Revue medicale de Liege·2007

Area of Science:

  • Pharmacology
  • Internal Medicine
  • Drug Development

Context:

  • Overview of recent pharmaceutical advancements in Belgium.
  • Focus on drugs relevant to internal medicine disciplines.

Purpose:

  • To describe important drugs registered and/or launched in Belgium.
  • To highlight key characteristics and appropriate clinical application of new molecules.

Summary:

  • Presents a curated list of significant new medications in Belgian internal medicine.
  • Details molecular properties and practical usage guidelines for clinicians.

Impact:

  • Aids healthcare providers in understanding and utilizing novel therapeutic agents.
  • Supports informed decision-making for patient treatment in internal medicine.